Insulet
PODD
#1277
Rank
NZ$29.37 B
Marketcap
NZ$417.27
Share price
-1.94%
Change (1 day)
-16.67%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): NZ$0.63 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$2.52 Billion. In 2024 the company made an earning of NZ$0.56 Billion, an increase over its 2023 earnings that were of NZ$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.63 B10.99%
2024 NZ$0.56 B36.76%
2023 NZ$0.41 B481.9%
2022 NZ$71.48 M-45.24%
2021 NZ$0.13 B43.35%
2020 NZ$91.05 M18.51%
2019 NZ$76.83 M41.16%
2018 NZ$54.43 M-711.95%
2017 -NZ$8.9 Million-56.85%
2016 -NZ$20.62 Million-79.31%
2015 -NZ$99.66 Million63.85%
2014 -NZ$60.83 Million31.04%
2013 -NZ$46.42 Million-21.96%
2012 -NZ$59.48 Million
2010 -NZ$56.73 Million-42.38%
2009 -NZ$98.46 Million-33.56%
2008 -NZ$0.15 Billion65.93%
2007 -NZ$89.31 Million209.75%
2006 -NZ$28.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.73 B 8,807.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.49 B 2,137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$10.63 B 1,662.44%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$37.32 B 6,087.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-NZ$0.34 Billion-156.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$0.20 B-65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$1.62 B 168.90%๐Ÿ‡บ๐Ÿ‡ธ USA